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ABSTRACT: Incorporation and controlled release of active substances from the conductive polypyrrole films by 
electric stimulation were investigated. Change of the redox state of the conductive polymer was induced by this 
stimulation, which allowed the incorporation and release of the drug at different rates. Polymerization of pyrrol 
on a stainless steel substrate was performed by cycling the potential 40 times in predetermined potential window, 
after which uniform polymeric film was formed and used as a medium for incorporation and release of the active 
substance. Stability of obtained films, as well as the electrochemical behaviour of ranitidine hydrochloride was 
investigated by cycling the potential of the film electrode in 0.9 % NaCl in the same potential window used for the 
polymerization. Uptake and release of the active substance was performed at constant potential and monitored by 
chronoamperometry. Although incorporation of the ranitidine hydrochloride was not obvious from the measured 
infrared spectra, incorporation and release was confirmed and quantified by monitoring the concentration of the 
active substance in the electrolyte. It was determined that maximum reversible uptake was 351 μg cm-2. However, 
successive potential stimuli did not result in the equal released quantity, as expected for the ideal controlled-
release system based on conducting polymers. 
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INTRODUCTION 
 It has always been considered that any substance 
can be seen either as a medicine or as a poison. It is 
important in all this to have a specific measure or 
dosage, by which we can manipulate the amount of 
active substance we need. Dosage, subjectively 
speaking, has different effects for each person, but 
each one has different visions and experiences. There 
are various variations on this subject, namely that the 
dosage alone depends on the physicochemical char-
acteristics of the drug, the organism and its metabo-
lism, to what extent the drug is dosed and in general 
how many times a day the drug is administered. 
 A special concept of administration and release 
of the drug into the organism has been developed 
through indirect "vectors", which will allow the re-
lease of the required amount of medication at a given 
time interval. In addition, apart from having a long-
term effect and controlling the release rate, multiple 
administration of the drug is avoided. 
 In order to achieve such an effect, it is necessary 
to pack the drug in a particular substance, which will 
be compatible with it, and which will exhibit such 
traits that will enable it to be released at the given 
location. More and more considerations come from 
polymers, where the drug is incorporated into their 
structure and as such release into the organism. In 
recent years, polypyrrole (PPy) is in the focus of 
many studies compared to other conductive polymers 
due to its high chemical stability and air stability and 
simple preparation. Oxidation of pyrrole into 
polypyrrole can be achieved by using an electro-
chemical or chemical method, with the addition of 
strong oxidizing agents ([1] Anuar et al., 2004). It 
can be easily modified to be more suitable for bio-
medical applications through the incorporation of 
bioactive molecules. Polipyrrole also responds to 
stimuli, enabling a dynamic control of its properties 
by applying electric potential ([2] Ateh et al., 2006). 
The need to prepare these materials in various forms 
in order to enable integration or linkage with other 
structures, including living beings, is of vital im-
portance ([3] Wallace et al., 2009). Polypyrrole is an 
electronically conductive polymer with conductivity 
up to 1000 Scm
-1
, demonstrating its versatile applica-
tion in batteries, electronic devices, functional elec-
trodes, electromagnetic devices, sensors, etc. It can 
be manufactured with a large surface, with different 
porosity or can be easily modified to be more suitable 
for biomedical applications through the incorporation 
of bioactive molecules. Polypyrrole also responds to 
stimuli, enabling dynamic control of its properties by 
applying electric potential ([2] Aten et al., 2006). 
These properties are well exploited in potential con-
trolled-release systems based on PPy ([4] Geetha et 
al., 2006; [5] Alshammary et al., 2016; [6] Thompson 
et al., 2006; [7] Kontturi et al., 1998) and derivatives 
([8] Krukiewicz et al., 2016), while some authors 
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claimed the preparation of PPy-based chip for con-
trolled release ([9] Ge et al., 2009). Also, some au-
thors addressed biocompatibility of PPy and PPy-
based materials, essential for their potential applica-
tion in biological systems ([2] Aten et al., 2006). 
The dosage represents the amount of active substance 
(drug) administered to a human or an animal. The 
dose-response and drug effect can be graded and 
quantal. Drug concentration in body after oral admin-
istration can be simplified and presented as concen-
tration-time profile (Figure 1). The rate at which the 
drug appears in the blood is defined by tmax, the time 
at which the drug achieves maximum concentration, 
and cmax or maximum concentration ([10] Mehmeda-
gić, 2002). 
 In this paper, incorporation of ranitidine hydro-
chloride into the electropolymerized polypyrrole ma-
trix, and its controlled release was performed by elec-
trochemical transformation of polymeric film. 
Ranitidine is a non-imidazolyl-blocker of histamine 
receptors that competitively antagonizes the action of 
histamine on all H2 receptors, but is mainly used to 
inhibit gastric acid secretion. Ranitidine is used in the 
treatment of the following diseases: intestinal sores 
and stomach ulcers; gastro-oesophageal reflux; ero-
sive esophagitis (http: 1). Ranitidine is administered 
orally and is well absorbed. 
 
 
Figure 1. Level of active substance concentration in plasma 
after: one dose, repeated dose, 
controlled release ([11] Babić, 2015)   
 
EXPERIMENTAL 
 Pyrrole, lithium perchlorate and camphorsulfonic 
acid (CSA) were of analytical grade and obtained 
from Sigma-Aldrich, USA. Pyrrole was distilled un-
der the reduced pressure prior to use. Ranitidine hy-
drochloride was of analytical grade and was obtained 
from Hemofarm, Serbia. Phosphate buffer was pre-
pared as following solution, with analytical grade 
chemicals: NaCl 8 gL
-1
, KCl 0.2 gL
-1
, Na2HPO4 1.42 
gL
-1
, KH2PO4 0.24 gL
-1
 + redistilled water. 
 The substrate was made of stainless steel with 
high content of nickel and chrome. It was used in the 
form of plates which were coated with Teflon tape in 
order to achieve the geometric surface area of 2 cm
2
 
exposed to the electrolyte (Figure 2). 
 
 
Figure 2. Stainless steel plate (in the middle) 
 
 The polymerization of pyrrole was performed 
using cyclic voltammmetry in a three electrode sys-
tem with Ag/AgCl/KClsat as the reference (0.197 V 
vs. SHE) and platinum foil (2 cm
2
) as auxiliary elec-
trode, by cycling the potential 40 times between -0.6 
and 0.6 V in 0.05 mol dm
-3
 pyrrole solution with 0.1 
mol dm
-3
 camphorsulfonic acid or lithium perchlorate 
as the inert electrolyte. Stainless steel plate was the 
working electrode. 
 Chronoamperometry was employed in order to 
incorporate the active substance, as well as to release 
it from the polypyrrole film. All electrochemical ex-
periments were performed with potenti-
ostat/galvanostat PAR 263A controlled by Pow-
erSTEP interface. The argon stream was passed 
through the cell several minutes prior to the start as 
well as during the measurement to remove oxygen 
from the electrolyte. The camphorsulfonate anions 
were used as large anions, which can be incorporated 
into the polymer to balance the positive charge 
caused by oxidation of the polymer during synthesis. 
After polymerization, the obtained film was washed 
with redistilled water and left in water until the next 
treatment. Characterization of polymer films was per-
formed by infrared spectroscopy with Fourier trans-
form using Perkin Elmer Spectrum BX. UV spectro-
photometry was used to determine the concentration 
of ranitidine hydrochloride in the buffered electrolyte 
after release. In this case a phosphate buffer was used 
as a blind test. The absorption spectrum in the ultra-
violet and visible area was recorded for the active 
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component dissolved in phosphate buffer. Molar ab-
sorption coefficient of the active substance is deter-
mined from the slope of absorbance-concentration 
dependence at the maximum absorbance. Measure-
ments were performed on the UV-Vis ultrasonic 
spectrophotometer 2000. The cyclic voltammmetry 
of the active component in the sodium chloride solu-
tion was performed to determine the electrochemical 
behaviour of this substance. Measurements were per-
formed in the previously described three electrode 
system, where the glassy carbon electrode was used 
as the working electrode. Measurements were made 
within the limits of the potential electrolyte window. 
 
 
Figure 3. The prochrome plate after using cyclic voltammmetry 
 Loading of the conductive polymer film with the 
active component was performed using a potenti-
ostatic method of highly concentrated aqueous solu-
tion (100 g/L) of the active component in the stand-
ard three electrode system. Charging of the polymer 
was performed at a potential of +0.60 V and moni-
tored using chronoamperometry. 
 Controlled release was performed in the same 
cell in a small volume of phosphate buffer solution 
(10 cm
3
), where the excitation signal was at the po-
tential of +0.55 V. After each signal from the cell, 
small volume was sampled and analyzed by means of 
UV spectrophotometry, after which analyzed solution 
was transferred back to the electrochemical cell for 
subsequent stimuli of PPy matrix. In addition, anoth-
er sample of the charged polymer was left for 24 
hours in the buffer solution, after which the buffer 
was analyzed for the content of the active compo-
nent, in order to determine spontaneous release. 
 
 
RESULTS AND DISCUSSION 
 Figure 4 shows the voltammograms recorded dur-
ing polymerization of pyrrole in two electrolytes: 
lithium perchlorate and camphorsulfonic acid. In 
both cases, voltammograms show the gradual growth 





Figure 4. Cyclovoltammograms of pyrrol polymerization on stainless steel; 
left: with LiClO4; right: with CSA as auxiliary electrolyte 
 
 However, in the case where the supporting elec-
trolyte is camphorsulfonic acid, it is noticeable that 
the current peaks induced by the redox transfor-
mation of the polypyrrole are considerably sharper 
and better defined, which is a result of significantly 
better kinetics of these processes than those in 
polypyrrole obtained with lithium perchlorate. Since 
the electronic transfer is a fast process and therefore 
cannot limit the speed, the reason for the different 
kinetics of redox transformation in the polypyrrole 
film lies at different diffusion rates of counter ions 
(perhlorate or camphor sulfonate) in the mass of the 
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polymer, which is in accordance with different sizes 
of these ions. Namely, using a relatively larger cam-
phorsulphonate anion, the formed polymer structure 
is looser, but also the anion is captured in the poly-
mer structure. For this reason, during the redox trans-
formation of this system, the cation diffusion (in the 
case of camphorsulfonic acid, H
+
 ions) becomes the 
dominant process. This fact represents an important 
precondition for the incorporation of cationic active 
components, such as ranitidine. 
 Figure 5 shows an infrared spectrum of electro-
chemically prepared polypyrrole with marked charac-
teristic vibration strings. 
 At 1422 cm
-1
 there are vibrations of C=C elonga-
tion of the pyrrol ring. At 1035 cm
-1
 there are N-H 
vibrations. At 1460 cm
-1
, the asymmetric stretching 
of the C-C bond was noticeably observed. At 1545 
cm
-1
 there is a characteristic peak of the pyrrol ring. 
 
Figure 5. Infrared spectrum of polypyrrole 
 
SPECTROSCOPIC CHARACTERIZATION AND 
ELECTROCHEMICAL PROPERTIES OF THE ACTIVE 
SUBSTANCE 
 Figure 6 shows the absorption spectrum of the 
active component. Ranitidine hydrochloride has two 
absorption maxima, at 230 nm and 310 nm. 
 
 Figure 7 shows the standard calibration curve, 
respecting Beer's law in a given range of 0.04 to 0.2 g 
dm
-3
. When subjected to a regression analysis, the 
value of the coefficient of regression in ranitidine 
hydrochloride is the value of coefficient 0.942. 
 
 
Figure 6. The absorption spectrum of ranitidine in the ultraviolet and visible area 
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Figure 7. The standard calibration curve of ranitidine hydrochloride 
 
 
 Figure 8 shows the infrared spectrum of 
ranitidine hydrochloride. For ranitidine hydrochloride 
the following peaks are characteristic: from 3260 cm
-
1
 to 3100 cm
-1
 for OH group stretching and symmet-
rical stretching of N-H peaks, bands around 3066 and 
3017 cm
-1
 are attributed to C-H bond of furan which 
is a part of the chemical structure of the active sub-
stance. 2970, 2950 and 2908 cm
-1
 bands are present 




Figure 8. Infrared spectrum of ranitidine 
 
 
 Figure 9 shows the infrared spectrum of 
ranitidine incorporated in a PPy film. Based on this 
IR spectrum, it is not possible to establish with cer-
tainty the presence of ranitidine hydrochloride, and 
the reason for this may be the low concentrations of 
the active substances in the conductive PPy film. 
However, our conclusion that the substance is actual-
ly absorbed into the film is based on the fact that the 
polymer film was oxidized in the solution containing 
only the active substance (no other counter ion to 
compensate the charge introduced by potentiostat), as 
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Figure 9. Infrared spectrum of ranitidine hydrochloride incorporated in polypyrrole film; the black spectrum - ranitidine hydrochloride and 
polypyrrole, the red spectrum - polypyrrole spectrum, the green spectrum - ranitidine hydrochloride 
 
CONTROLLED RELEASE 
 Figure 10 shows the cyclovoltammogram of the 
active component in 0.9% NaCl. Given that the 
measurements worked in a potential window, it is 
concluded from this data that the active component in 




Figure 10. Cyclovoltammogram of ranitidine hydrochloride in 0.9% NaCl 
 
 Since the loading of polymer film implies its re-
dox transformation, whereby the counter-ions of the 
electrolyte (in this case, the ions of the active sub-
stance) are incorporated into the polymer to maintain 
its electroneutrality, the amount of incorporated ac-
tive substance can be estimated from the total charge 
passed through the electrochemical cell during the 
charging of the film. This charge is obtained from the 
chronoamperamograms scanned during film loading 
(Figure 11), and it amounts to 96.53 mC for 
ranitidine hydrochloride. Based on Faraday's law: 




where z=1, F=96500 C mol
-1
 and Q the above men-
tioned charge, the estimated incorporated amount of 
the active substance is 1.00 × 10
-6
 mol or 351 μg 
ranitidine hydrochloride. 
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Figure 11. Chronoamperogram showing the incorporation of 
ranitidine hydrochloride into a polypyrrole film at a given time 
 
 The release was carried out in a small volume of 
phosphate buffer (10 cm
3
) to obtain a concentrated 
solution for spectrophotometric analysis. Table 1 
shows the abundance absorbance values after each 
excitation signal (1 second), as well as the calculated 
values of the concentration of the released active sub-
stance in the buffer. By measuring absorbance of 
buffer solution with control samples that were left for 
24 h without the excitation signal, it was found that 
no measurable release of the active substance had 
occurred. Based on this, using the estimated value of 
the weight of the drug incorporated, the relative 
amount of drug release was calculated in percentages, 
which is also shown in the table. Figure 12 gives 
graphical representation of data from the table above. 
 




1 2 3 4 5 
A 0.011 0.029 0.046 0.052 0.063 
c / mmol 
dm-3 
3.65 9.63 15.27 17.26 20.91 
nuk / μmol 36.5 96.3 152.7 172.6 209.1 
ndif / μmol 36.5 59.8 56.4 19.9 36.5 
% released 
in total 
10.40 30.00 47.57 53.77 65.14 
 
 
Figure 12. Total and individual amounts of released ranitidine 
and percentage of total released amount in the function of the stimulus 
 
From the data shown above, it is apparent that at each 
excitation potential signal, a controlled release of the 
active substance is achieved. It is noteworthy, how-
ever, that the released amount varies during succes-
sive stimuli, which would ideally be the same (open 
circles in Figure 12), whereas the total released 
amount has a steady trend of growth. 
 
CONCLUSION 
 From the results of the research it can be con-
cluded: 
 that after cyclic voltammmetry, the polymeriza-
tion of polypyrrole on a thin plate was success-
fully performed. After 40 cycles over a period of 
45 minutes, a unique film was formed, which 
was used as a medium for incorporating and re-
leasing active substances. 
 The use of camphorsulfonic acid as an electrolyte 
has proven to be a better choice because the bulk 
anion creates a looser polypyrrole structure, 
which will allow the recipience of a greater num-
ber of anions, which will later be important in the 
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ion exchange with the active substance (in this 
case cations). 
 Through infrared spectroscopy it was possible to 
obtain infrared spectra for polypyrrole and the 
active substance, but after the incorporation of 
the active substance into the polypyrrole film, 
spectral spikes could not be read clearly. The rea-
son may be insufficient concentration of the ac-
tive substance, which on the other hand means a 
small amount of incorporated active substance in 
the conductive polypyrrole film. 
 Cyclovoltammmetric analysis of ranitidine was 
also performed in 0.9% NaCl solution within the 
potential window (potential range in which there 
is no electrolyte degradation). Based on this it 
can be concluded that the active substance in the 
range of these potentials will not be electrochem-
ically dissolved. 
 Chronoamperometry can be used to determine the 
amount of active substance incorporated into a 
conductive polypyrrole film, following Faraday's 
law, where for ranitidine hydrochloride amounts 
to 1.00 × 10
-6
 mole or 351 μg. 
 In addition to loading, chronoamperometry was 
also used for the release of the active substance 
from the conductive polypyrrole film. Low val-
ues of absorbances may indicate low concentra-
tions of the active substance, instrument failure, 
or much more advanced techniques and materials 
are needed to enable higher concentrations of ac-
tive component, as well as their loading and re-
lease from the polypyrrole film. 
 It is noteworthy, however, that the released 
amount varies with successive stimuli, which 
should ideally be the same as the total released 
quantity has a steady growth trend. 
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